DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $21,019 | -8.1% | 90,857 | -1.5% | 1.72% | -15.8% |
| Q3 2023 | $22,879 | +3.5% | 92,215 | +0.2% | 2.04% | +7.3% |
| Q2 2023 | $22,098 | -1.1% | 92,075 | +3.9% | 1.90% | -6.0% |
| Q1 2023 | $22,338 | -5.1% | 88,630 | -0.1% | 2.02% | -8.5% |
| Q4 2022 | $23,542 | -99.9% | 88,699 | -1.8% | 2.21% | -3.7% |
| Q3 2022 | $23,341,000 | +1.5% | 90,368 | -0.4% | 2.30% | +11.5% |
| Q2 2022 | $22,995,000 | -13.5% | 90,703 | -0.4% | 2.06% | +4.3% |
| Q1 2022 | $26,577,000 | -12.4% | 91,113 | -1.2% | 1.98% | -8.1% |
| Q4 2021 | $30,340,000 | +8.0% | 92,216 | -0.1% | 2.15% | -1.5% |
| Q3 2021 | $28,094,000 | +12.7% | 92,282 | -0.7% | 2.18% | +13.7% |
| Q2 2021 | $24,928,000 | +16.0% | 92,890 | -2.7% | 1.92% | +7.9% |
| Q1 2021 | $21,482,000 | -0.7% | 95,440 | -2.0% | 1.78% | -5.1% |
| Q4 2020 | $21,640,000 | -3.0% | 97,418 | -6.0% | 1.87% | -11.0% |
| Q3 2020 | $22,306,000 | +22.9% | 103,588 | +0.9% | 2.10% | +12.3% |
| Q2 2020 | $18,156,000 | -39.5% | 102,673 | -50.1% | 1.88% | +15.0% |
| Q1 2020 | $30,009,000 | +89.8% | 205,594 | +99.5% | 1.63% | +5.1% |
| Q4 2019 | $15,815,000 | +11.6% | 103,044 | +5.0% | 1.55% | +3.4% |
| Q3 2019 | $14,172,000 | +1.7% | 98,123 | +0.6% | 1.50% | +1.7% |
| Q2 2019 | $13,936,000 | +6.0% | 97,508 | -2.1% | 1.48% | +5.8% |
| Q1 2019 | $13,149,000 | +31.9% | 99,599 | +3.0% | 1.39% | +15.2% |
| Q4 2018 | $9,972,000 | -3.3% | 96,700 | +1.9% | 1.21% | +18.9% |
| Q3 2018 | $10,309,000 | +95.9% | 94,880 | +77.9% | 1.02% | +83.4% |
| Q2 2018 | $5,263,000 | +4.6% | 53,332 | +3.8% | 0.56% | 0.0% |
| Q1 2018 | $5,032,000 | +5.1% | 51,392 | -0.3% | 0.56% | +10.1% |
| Q4 2017 | $4,786,000 | +9.6% | 51,562 | +1.3% | 0.50% | +3.5% |
| Q3 2017 | $4,367,000 | +7.8% | 50,912 | +6.0% | 0.49% | +5.2% |
| Q2 2017 | $4,052,000 | -2.5% | 48,012 | -1.1% | 0.46% | -2.7% |
| Q1 2017 | $4,154,000 | +5.1% | 48,562 | -4.3% | 0.48% | +2.1% |
| Q4 2016 | $3,952,000 | -1.9% | 50,762 | -1.2% | 0.47% | -1.7% |
| Q3 2016 | $4,027,000 | -19.7% | 51,362 | +3.4% | 0.47% | -21.1% |
| Q2 2016 | $5,015,000 | +1.2% | 49,652 | -4.9% | 0.60% | -0.2% |
| Q1 2016 | $4,954,000 | +1.7% | 52,227 | -0.4% | 0.60% | +2.9% |
| Q4 2015 | $4,870,000 | +5.9% | 52,427 | -2.9% | 0.58% | +3.7% |
| Q3 2015 | $4,599,000 | -2.6% | 53,973 | -2.2% | 0.56% | +9.1% |
| Q2 2015 | $4,722,000 | -6.8% | 55,173 | -7.5% | 0.52% | -1.7% |
| Q1 2015 | $5,064,000 | -8.3% | 59,648 | -7.4% | 0.53% | -5.9% |
| Q4 2014 | $5,522,000 | +9.9% | 64,423 | -2.6% | 0.56% | +12.9% |
| Q3 2014 | $5,024,000 | -3.6% | 66,123 | -0.1% | 0.50% | -5.4% |
| Q2 2014 | $5,211,000 | +4.8% | 66,193 | -0.2% | 0.52% | -2.8% |
| Q1 2014 | $4,974,000 | -3.9% | 66,318 | -1.1% | 0.54% | -3.9% |
| Q4 2013 | $5,177,000 | +6.6% | 67,057 | -4.3% | 0.56% | -1.1% |
| Q3 2013 | $4,857,000 | +7.0% | 70,057 | -2.3% | 0.57% | +2.9% |
| Q2 2013 | $4,541,000 | – | 71,732 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |